Cite

HARVARD Citation

    Gunaratne, P. et al. (2019). Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53‐altered tumors. Cancer. 125 (14), pp. 2409-2422. [Online]. 
  
Back to record